Mutated ACVR1 for diagnosis and treatment of Fibrodyplasia Ossificans Progressiva (FOP)

• 收藏
• 分享

专利权人:

THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA

发明人:

Kaplan Frederick S.,Shore Eileen M.

申请号：

US201414521143

公开号：

US10106852(B2)

申请日:

2014.10.22

申请国别(地区):

美国

年份:

2018

代理人:

Cohen Mark S.`Pearl Cohen Zedek Latzer Baratz LLP

摘要：

This invention is directed to mutated Activin A type I receptor proteins (ACVR1) and isolated nucleic acids encoding same. The invention also relates to the use of mutated ACVR1 in the diagnosis and treatment of Fibrodysplasia Ossificans Progressiva (FOP).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/